{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:49:57Z","timestamp":1792028997885,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005227","name":"Jilin Provincial Department of Health","doi-asserted-by":"publisher","award":["2024WSZX-D20"],"award-info":[{"award-number":["2024WSZX-D20"]}],"id":[{"id":"10.13039\/501100005227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114390","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:34:21Z","timestamp":1741588461000},"page":"114390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["GLP-1 as a regulator of sepsis outcomes: Insights into cellular metabolism, inflammation, and therapeutic potential"],"prefix":"10.1016","volume":"152","author":[{"given":"Weixuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2025.114390_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10219","key":"10.1016\/j.intimp.2025.114390_bb0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.tem.2022.01.006","article-title":"Sepsis: a failing starvation response","volume":"33","author":"Vandewalle","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"195","key":"10.1016\/j.intimp.2025.114390_bb0020","doi-asserted-by":"crossref","first-page":"195ra95","DOI":"10.1126\/scitranslmed.3005893","article-title":"An integrated clinico-metabolomic model improves prediction of death in sepsis","volume":"5","author":"Langley","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.114390_bb0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00018-022-04490-0","article-title":"Metabolic reprogramming consequences of sepsis: adaptations and contradictions","volume":"79","author":"Liu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.114390_bb0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.114390_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104615","article-title":"Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure","volume":"152","author":"Yoon","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/pr.108.000604","article-title":"The role of incretins in glucose homeostasis and diabetes treatment","volume":"60","author":"Kim","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0045","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2025.114390_bb0050","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db14-0100","article-title":"GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering","volume":"63","author":"Kahles","year":"2014","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0055","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.intimp.2025.114390_bb0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.amjmed.2017.03.010","article-title":"GLP-1 levels predict mortality in patients with critical illness as well as end-stage renal disease","volume":"130","author":"Lebherz","year":"2017","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jamcollsurg.2019.04.014","article-title":"Persistently elevated glucagon-like Peptide-1 levels among critically ill surgical patients after Sepsis and development of chronic critical illness and dismal long-term outcomes","volume":"229","author":"Brakenridge","year":"2019","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2982","article-title":"Sepsis-induced activation of endogenous GLP-1 system is enhanced in type 2 diabetes","volume":"34","author":"Perl","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.intimp.2025.114390_bb0075","doi-asserted-by":"crossref","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2025.114390_bb0080","doi-asserted-by":"crossref","first-page":"1148209","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114390_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.07.015","article-title":"Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds","volume":"812","author":"Insuela","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114390_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171200","article-title":"Immunomodulation and inflammation: role of GLP-1R and GIPR expressing cells within the gut","volume":"176","author":"Morrow","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2025.114390_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab."},{"key":"10.1016\/j.intimp.2025.114390_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101180","article-title":"GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer\u2019s disease","volume":"47","author":"Zheng","year":"2021","journal-title":"Mol Metab."},{"issue":"9","key":"10.1016\/j.intimp.2025.114390_bb0105","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1478-3231.2011.02462.x","article-title":"Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis","volume":"31","author":"Svegliati-Baroni","year":"2011","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/SHK.0000000000001683","article-title":"Hyper-activation of endogenous GLP-1 system to gram-negative Sepsis is associated with early innate immune response and modulated by diabetes","volume":"55","author":"Bloch","year":"2021","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.intimp.2025.114390_bb0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like Peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0125","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jcb.24425","article-title":"Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP\/PKA pathway","volume":"114","author":"Chang","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0130","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/acs.biomac.5b01756","article-title":"Trimeric PEG-conjugated Exendin-4 for the treatment of Sepsis","volume":"17","author":"Lee","year":"2016","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114390_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105969","article-title":"Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages","volume":"77","author":"Lu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2014.10.015","article-title":"Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the G\u03b1q pathway","volume":"93","author":"Thompson","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114390_bb0150","article-title":"GLP-1 receptor: a new target for Sepsis","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0155","first-page":"669","article-title":"Role of cytokines as a double-edged sword in sepsis","volume":"27","author":"Chaudhry","year":"2013","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0160","first-page":"161","article-title":"Cytokines in the systemic inflammatory response syndrome: a review","volume":"2","author":"Jaffer","year":"2010","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth."},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/db13-0903","article-title":"Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway","volume":"63","author":"Nguyen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114390_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-016-0330-8","article-title":"Interleukin-6 predicts inflammation-induced increase of glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism","volume":"15","author":"Lebherz","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbrc.2019.01.055","article-title":"Toll-like receptor 4 is necessary for glucose-dependent glucagon-like peptide-1 secretion in male mice","volume":"510","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.intimp.2025.114390_bb0180","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SHK.0000000000001334","article-title":"Inhibition of aerobic glycolysis promotes neutrophil to influx to the infectious site via CXCR2 in Sepsis","volume":"53","author":"Tan","year":"2020","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.intimp.2025.114390_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165542","article-title":"Glycolysis dependent lactate formation in neutrophils: a metabolic link between NOX-dependent and independent NETosis","volume":"1865","author":"Awasthi","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"9","key":"10.1016\/j.intimp.2025.114390_bb0195","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"18","key":"10.1016\/j.intimp.2025.114390_bb0200","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/molecules25184112","article-title":"Ethyl pyruvate promotes proliferation of regulatory T cells by increasing glycolysis","volume":"25","author":"Koprivica","year":"2020","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.intimp.2025.114390_bb0205","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/molecules25184112","article-title":"Ethyl pyruvate promotes proliferation of regulatory T cells by increasing glycolysis","volume":"25","author":"Koprivica","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0210","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114390_bb0215","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. Alternatively Activated Macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0220","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/SHK.0000000000001549","article-title":"Bone marrow mesenchymal stem cell-derived exosomes attenuate LPS-induced ARDS by modulating macrophage polarization through inhibiting glycolysis in macrophages","volume":"54","author":"Deng","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2025.114390_bb0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbi.2017.11.003","article-title":"AMPK regulates immunometabolism in sepsis","volume":"72","author":"Huang","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0230","first-page":"R393","article-title":"Exogenous GLP-1 stimulates TCA cycle and suppresses gluconeogenesis and ketogenesis in late-fasted northern elephant seals pups","volume":"320","author":"Dhillon","year":"2021","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0235","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.124.320714","article-title":"Novel angiogenesis role of GLP-1(32-36) to rescue diabetic ischemic lower limbs via GLP-1R-dependent glycolysis in mice","volume":"44","author":"Zhang","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0240","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911319","article-title":"Hepatic PPAR\u03b1 function and lipid metabolic pathways are dysregulated in polymicrobial sepsis","volume":"12","author":"Van Wyngene","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12916-020-01546-5","article-title":"Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation","volume":"18","author":"Wang","year":"2020","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167060","article-title":"GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis","volume":"1870","author":"Shen","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/dna.2024.0057","article-title":"Anti-inflammatory effects of glucagon-like Peptide-1 receptor agonists via the Neuroimmune Axis","volume":"43","author":"Fang","year":"2024","journal-title":"DNA Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0260","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/08830185.2015.1087518","article-title":"The characteristics and function of bacterial lipopolysaccharides and their Endotoxic potential in humans","volume":"35","author":"Gnauck","year":"2016","journal-title":"Int. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0270","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/ajcn\/86.5.1286","article-title":"A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation","volume":"86","author":"Erridge","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0275","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2353\/ajpath.2010.091069","article-title":"Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model","volume":"176","author":"Grootjans","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1753425909339231","article-title":"Regulation of toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis","volume":"16","author":"Vamadevan","year":"2010","journal-title":"Innate Immun."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0285","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.114390_bb0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0295","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.intimp.2025.114390_bb0300","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/db14-1577","article-title":"GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R","volume":"64","author":"Yusta","year":"2015","journal-title":"Diabetes"},{"issue":"35","key":"10.1016\/j.intimp.2025.114390_bb0305","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1073\/pnas.0809784106","article-title":"Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB","volume":"106","author":"Porta","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.intimp.2025.114390_bb0310","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.4049\/jimmunol.1001952","article-title":"Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells","volume":"186","author":"Pena","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0315","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jcb.24425","article-title":"Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP\/PKA pathway","volume":"114","author":"Chang","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.114390_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105969","article-title":"Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages","volume":"77","author":"Lu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pharep.2015.10.008","article-title":"Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes\/macrophages in a protein kinase a and B\/Akt manner","volume":"68","author":"Bu\u0142dak","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2025.114390_bb0330","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0340","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"Nauck","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"8","key":"10.1016\/j.intimp.2025.114390_bb0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/JIR.S84993","article-title":"Effects of exendin-4, a glucagon like peptide-1 receptor agonist, on neutrophil count and inflammatory cytokines in a rat model of endotoxemia","volume":"2015","author":"Yanay","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.114390_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114348","article-title":"Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis","volume":"363","author":"Yi","year":"2023","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0355","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.intimp.2025.114390_bb0360","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fnins.2017.00500","article-title":"Plant polyphenols and Exendin-4 prevent hyperactivity and TNF-\u03b1 release in LPS-treated in vitro neuron\/astrocyte\/microglial networks","volume":"11","author":"Gullo","year":"2017","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0365","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jnr.23335","article-title":"Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents","volume":"92","author":"Iwai","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.intimp.2025.114390_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176191","article-title":"Intranasal Exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise","volume":"961","author":"Zaky","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114390_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039656","article-title":"Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0380","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12035-016-0307-3","article-title":"Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice","volume":"55","author":"Neves","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/JPD-171068","article-title":"Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines","volume":"7","author":"Ventorp","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"17","key":"10.1016\/j.intimp.2025.114390_bb0390","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1007\/s00253-018-9155-6","article-title":"Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1","volume":"102","author":"Chen","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0395","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41374-018-0170-0","article-title":"Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function","volume":"99","author":"Xu","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.intimp.2025.114390_bb0400","doi-asserted-by":"crossref","first-page":"3601454","DOI":"10.1155\/2018\/3601454","article-title":"GLP-1 analogue Liraglutide enhances SP-A expression in LPS-induced acute lung injury through the TTF-1 signaling pathway","volume":"2018","author":"Zhu","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0405","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SHK.0000000000002285","article-title":"Liraglutide alleviates acute lung injury and mortality in pneumonia-induced SEPSIS through regulating surfactant protein expression and secretion","volume":"61","author":"Guo","year":"2024","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0410","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/08923973.2024.2384897","article-title":"Liraglutide alleviates sepsis-induced acute lung injury by regulating pulmonary surfactant through inhibiting autophagy","volume":"46","author":"Guo","year":"2024","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0415","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12931-017-0660-4","article-title":"Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition","volume":"18","author":"Suzuki","year":"2017","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0420","first-page":"L834","article-title":"DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice","volume":"315","author":"Kawasaki","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.intimp.2025.114390_bb0425","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejphar.2016.10.016","article-title":"Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice","volume":"791","author":"Zhou","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0430","first-page":"L368","article-title":"Liraglutide pretreatment attenuates sepsis-induced acute lung injury","volume":"325","author":"Baer","year":"2023","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.intimp.2025.114390_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175730","article-title":"Dulaglutide provides protection against sepsis-induced lung injury in mice by inhibiting inflammation and apoptosis","volume":"949","author":"Wang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0440","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.intimp.2025.114390_bb0445","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.3390\/ijms221910822","article-title":"Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists","volume":"22","author":"Winiarska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114390_bb0450","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fphar.2018.01168","article-title":"GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41366-021-00955-7","article-title":"Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist","volume":"46","author":"Pontes-da-Silva","year":"2022","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0460","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s13054-020-03327-1","article-title":"Gut-liver crosstalk in sepsis-induced liver injury","volume":"24","author":"Sun","year":"2020","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/apt.15316","article-title":"Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and\/or obesity","volume":"50","author":"Newsome","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0470","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.aohep.2019.04.011","article-title":"The GLP-1 analog liraglutide attenuates acute liver injury in mice","volume":"18","author":"Milani","year":"2019","journal-title":"Ann. Hepatol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114390_bb0475","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/liv.14888","article-title":"Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis","volume":"41","author":"Perakakis","year":"2021","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0480","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1248\/bpb.b14-00505","article-title":"The glucagon-like Peptide-1 analogue Liraglutide inhibits oxidative stress and inflammatory response in the liver of rats with diet-induced non-alcoholic fatty liver disease","volume":"38","author":"Gao","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"17","key":"10.1016\/j.intimp.2025.114390_bb0485","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.intimp.2025.114390_bb0490","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.3390\/ijms20236024","article-title":"Renal tubular glucagon-like Peptide-1 receptor expression is increased in early Sepsis but reduced in chronic kidney disease and Sepsis-induced kidney injury","volume":"20","author":"Choi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0495","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/acs.biomac.5b01756","article-title":"Trimeric PEG-conjugated Exendin-4 for the treatment of Sepsis","volume":"17","author":"Lee","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.intimp.2025.114390_bb0500","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1479-5876-11-270","article-title":"Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction","volume":"11","author":"Chen","year":"2013","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0505","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ddr.21863","article-title":"MicroRNA-214-5p aggravates sepsis-related acute kidney injury in mice","volume":"83","author":"Guo","year":"2022","journal-title":"Drug Dev. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.114390_bb0510","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3892\/etm.2016.3255","article-title":"Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-\u03baB pathway inhibition","volume":"11","author":"Lin","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2025.114390_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110311","article-title":"Tirzepatide attenuates lipopolysaccharide-induced left ventricular remodeling and dysfunction by inhibiting the TLR4\/NF-kB\/NLRP3 pathway","volume":"120","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1479164115605000","article-title":"Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis","volume":"13","author":"Gaspari","year":"2016","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-015-0518-1","article-title":"Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages","volume":"111","author":"Tate","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0530","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/08923973.2011.630398","article-title":"Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protects H9c2 cells from apoptosis","volume":"34","author":"Chen","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2025.114390_bb0535","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00210-010-0559-9","article-title":"GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats","volume":"382","author":"Ku","year":"2010","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114390_bb0540","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.peptides.2009.06.019","article-title":"Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation","volume":"30","author":"Dozier","year":"2009","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097554","article-title":"Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism","volume":"9","author":"Krasner","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0550","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00395-015-0465-x","article-title":"Gliptin and GLP-1 analog treatment improves survival and vascular inflammation\/dysfunction in animals with lipopolysaccharide-induced endotoxemia","volume":"110","author":"Steven","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114390_bb0555","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bph.13549","article-title":"Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice","volume":"174","author":"Steven","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114390_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117778","article-title":"Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis","volume":"182","author":"Delic","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0565","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvs246","article-title":"Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition","volume":"96","author":"Kr\u00f6ller-Sch\u00f6n","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.114390_bb0570","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/antiox10081175","article-title":"GLP-1 analog Liraglutide improves vascular function in Polymicrobial Sepsis by reduction of oxidative stress and inflammation","volume":"10","author":"Helmst\u00e4dter","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.intimp.2025.114390_bb0575","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s10753-014-9919-9","article-title":"Exendin-4 inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis","volume":"37","author":"Lee","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.114390_bb0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.regpep.2013.03.004","article-title":"Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for GLP-1 in modulation of the diabetic pro-inflammatory state","volume":"183","author":"Daousi","year":"2013","journal-title":"Regul. Pept."},{"issue":"4","key":"10.1016\/j.intimp.2025.114390_bb0585","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","article-title":"Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus","volume":"57","author":"Hogan","year":"2014","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0590","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.intimp.2025.114390_bb0595","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/phar.1301","article-title":"Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial","volume":"33","author":"Derosa","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.intimp.2025.114390_bb0600","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.metabol.2012.09.004","article-title":"A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients","volume":"62","author":"Satoh-Asahara","year":"2013","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0605","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1038\/s41467-024-50199-y","article-title":"GLP-1 receptor agonists\u2019 impact on cardio-renal outcomes and mortality in T2D with acute kidney disease","volume":"15","author":"Pan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114390_bb0610","article-title":"Corticosteroids for treating Sepsis in adult patients: a systematic review and Meta-analysis","volume":"12","author":"Liang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114390_bb0615","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","article-title":"Corticosteroids in septic shock: a systematic review and network meta-analysis","volume":"21","author":"Gibbison","year":"2017","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0620","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/nu12020292","article-title":"The emerging role of vitamin C as a treatment for Sepsis","volume":"12","author":"Kashiouris","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.intimp.2025.114390_bb0625","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","article-title":"Metabolic Messengers: glucagon-like peptide 1","volume":"3","author":"Gribble","year":"2021","journal-title":"Nat. Metab."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:09:09Z","timestamp":1757912949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925003807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":125,"alternative-id":["S1567576925003807"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114390","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 as a regulator of sepsis outcomes: Insights into cellular metabolism, inflammation, and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114390"}}